92 related articles for article (PubMed ID: 24795025)
21. SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions.
Keller KE; Tan IS; Lee YS
Science; 2012 Nov; 338(6110):1069-72. PubMed ID: 23086999
[TBL] [Abstract][Full Text] [Related]
22. Preparation of 5-amino-4-imidazole-N-succinocarboxamide ribotide, 5-amino-4-imidazole-N-succinocarboxamide riboside and succinyladenosine, compounds usable in diagnosis and research of adenylosuccinate lyase deficiency.
Zikánová M; Krijt J; Hartmannová H; Kmoch S
J Inherit Metab Dis; 2005; 28(4):493-9. PubMed ID: 15902552
[TBL] [Abstract][Full Text] [Related]
23. Activators of PKM2 in cancer metabolism.
Warner SL; Carpenter KJ; Bearss DJ
Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
[TBL] [Abstract][Full Text] [Related]
24. PKM2 gene regulates the behavior of pancreatic cancer cells via mitogen-activated protein kinase pathways.
Feng J; Ma T; Ge Z; Lin J; Ding W; Chen H; Zhu W; Zhou S; Tan Y
Mol Med Rep; 2015 Mar; 11(3):2111-7. PubMed ID: 25411978
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of a methylene analog of 5-amino-1-beta-D-ribofuranosylimidazole-4-carboxamide monophosphate (ZMP).
Kohyama N; Hayashi T; Yamamoto Y
Biosci Biotechnol Biochem; 2005 Apr; 69(4):836-8. PubMed ID: 15849426
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of nucleosides as potential inhibitors of purine biosynthesis.
Buchanan JG; Wightman RH
Nucleic Acids Symp Ser; 1991; (25):53-4. PubMed ID: 1842094
[TBL] [Abstract][Full Text] [Related]
27. Yeast AMP pathway genes respond to adenine through regulated synthesis of a metabolic intermediate.
Rébora K; Desmoucelles C; Borne F; Pinson B; Daignan-Fornier B
Mol Cell Biol; 2001 Dec; 21(23):7901-12. PubMed ID: 11689683
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologic activation of PKM2 slows lung tumor xenograft growth.
Parnell KM; Foulks JM; Nix RN; Clifford A; Bullough J; Luo B; Senina A; Vollmer D; Liu J; McCarthy V; Xu Y; Saunders M; Liu XH; Pearce S; Wright K; O'Reilly M; McCullar MV; Ho KK; Kanner SB
Mol Cancer Ther; 2013 Aug; 12(8):1453-60. PubMed ID: 23720766
[TBL] [Abstract][Full Text] [Related]
29. PKM2: a gatekeeper between growth and survival.
Harris I; McCracken S; Mak TW
Cell Res; 2012 Mar; 22(3):447-9. PubMed ID: 22184007
[No Abstract] [Full Text] [Related]
30. Discovery of 3-(trifluoromethyl)-1H-pyrazole-5-carboxamide activators of the M2 isoform of pyruvate kinase (PKM2).
Xu Y; Liu XH; Saunders M; Pearce S; Foulks JM; Parnell KM; Clifford A; Nix RN; Bullough J; Hendrickson TF; Wright K; McCullar MV; Kanner SB; Ho KK
Bioorg Med Chem Lett; 2014 Jan; 24(2):515-9. PubMed ID: 24374270
[TBL] [Abstract][Full Text] [Related]
31. Changes in PKM2 associate with prostate cancer progression.
Wong N; Yan J; Ojo D; De Melo J; Cutz JC; Tang D
Cancer Invest; 2014 Aug; 32(7):330-8. PubMed ID: 24884829
[TBL] [Abstract][Full Text] [Related]
32. Dual roles of PKM2 in cancer metabolism.
Wu S; Le H
Acta Biochim Biophys Sin (Shanghai); 2013 Jan; 45(1):27-35. PubMed ID: 23212076
[TBL] [Abstract][Full Text] [Related]
33. Evidence for the direct transfer of the carboxylate of N5-carboxyaminoimidazole ribonucleotide (N5-CAIR) to generate 4-carboxy-5-aminoimidazole ribonucleotide catalyzed by Escherichia coli PurE, an N5-CAIR mutase.
Meyer E; Kappock TJ; Osuji C; Stubbe J
Biochemistry; 1999 Mar; 38(10):3012-8. PubMed ID: 10074353
[TBL] [Abstract][Full Text] [Related]
34. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
[TBL] [Abstract][Full Text] [Related]
35. [Metabolism enzyme controls cancer stemness].
Konno M; Doki Y; Mori M; Ishii H
Nihon Rinsho; 2015 May; 73(5):745-50. PubMed ID: 25985625
[TBL] [Abstract][Full Text] [Related]
36. [MiR-124 suppresses the proliferation of human prostate cancer PC3 cells by targeting PKM2].
Lü L; Yuan JD; Cao ZL; Huang T; Zhang CH; Wang L; Zeng FQ
Zhonghua Nan Ke Xue; 2014 Jun; 20(6):495-9. PubMed ID: 25029852
[TBL] [Abstract][Full Text] [Related]
37. Molecular prejudice: RNA discrimination against purines allows response to a cellular alarm.
Ruehle MD; Kieft JS
Nat Struct Mol Biol; 2015 Oct; 22(10):754-6. PubMed ID: 26439636
[No Abstract] [Full Text] [Related]
38. AMPK or ZMPK?
Shakulov RS
Med Hypotheses; 2006; 67(3):670. PubMed ID: 16762515
[No Abstract] [Full Text] [Related]
39. Fragment-based drug discovery using cryo-EM.
Saur M; Hartshorn MJ; Dong J; Reeks J; Bunkoczi G; Jhoti H; Williams PA
Drug Discov Today; 2020 Mar; 25(3):485-490. PubMed ID: 31877353
[TBL] [Abstract][Full Text] [Related]
40. Small-molecule targeting of heat shock protein 90 chaperone function: rational identification of a new anticancer lead.
Meli M; Pennati M; Curto M; Daidone MG; Plescia J; Toba S; Altieri DC; Zaffaroni N; Colombo G
J Med Chem; 2006 Dec; 49(26):7721-30. PubMed ID: 17181154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
